Ticker
TVRDCompany Name
TVARDI THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Dividends & Other Cash Distributions | Payout Yield |
---|---|---|---|---|
6/30/2025 | $ 223.09M | $ 424K | $ 0 | -0.19% |
3/31/2025 | $ 248.44M | $ 0 | $ 0 | 0% |
12/31/2024 | $ 23.44M | $ 0 | $ 0 | 0% |
9/30/2024 | $ 17.97M | $ 1K | $ 0 | -0.01% |
6/30/2024 | $ 18.02M | $ 1.12M | $ 0 | -6.2% |
3/31/2024 | $ 41.02M | $ 1.12M | $ 0 | -2.72% |
12/31/2023 | $ 54.12M | $ 1.68M | $ 0 | -3.1% |
9/30/2023 | $ 64.29M | $ 1.7M | $ 0 | -2.64% |
6/30/2023 | $ 159.53M | $ 686K | $ 0 | -0.43% |
3/31/2023 | $ 224.03M | $ 868K | $ 0 | -0.39% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends) / Market Cap
(=) Payout Yield
Payout Yield for TVARDI THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 699K ] -1 * CF - Dividends [ $ 0 ]) / Market Cap [ $ 723.06M ]
(=) Payout Yield [ -0.1% ]
Minimum
Mar 31, 2022
Maximum
Dec 31, 2024
Average
Median
filtered constituents | 3.53K |
---|---|
min | -15.69% |
max | 16.92% |
average | 1.82% |
median | 1.33% |
std | 5.11% |